Karyopharm Therapeutics Inc.

Ownership Transactions Reported by 22 Insiders

Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
Location
85 Wells Avenue, Second Floor, Newton, MA

Insiders trading volume in the past year

Karyopharm Therapeutics Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sharon Shacham Chief Scientific Officer $1.37M Mar 29, 2022
Michael Kauffman Director $1.32M Feb 28, 2022
Michael Mason EVP, CFO & Treasurer $761K -$5.73K -0.75% Sep 4, 2024
Richard Paulson President and CEO, Director $309K -$32.9K -9.61% Apr 4, 2025
Ran Frenkel EVP, Chief Dev. Officer $138K Feb 28, 2022
Macomber Lori EVP, CFO & Treasurer $125K Jan 31, 2025
Jatin Shah EVP, Chief Medical Officer $106K Feb 17, 2022
Stephen Mitchener SVP, Chief Business Officer $105K Feb 28, 2023
Garen Bohlin Director $37K May 29, 2024
Sohanya Cheng EVP & Chief Commercial Officer $21.6K -$3.87K -15.2% Mar 4, 2025
Reshma Rangwala EVP & Chief Medical Officer $18.4K -$7.94K -30.1% Mar 4, 2025
Stuart Poulton EVP, Chief Development Officer $17.3K -$6.78K -28.2% Mar 4, 2025
Michael Mano SVP, General Counsel&Secretary $13.3K -$2.87K -17.8% Mar 4, 2025
Kristin Abate Chief Accounting Officer $6.12K Mar 4, 2025
Deepika Pakianathan Director $0 -$1.67M -100% Jun 5, 2024
Mikael Dolsten Director May 21, 2021
Peter Honig Director May 24, 2023
Mansoor Raza Mirza Director May 29, 2024
Chen Schor Director May 29, 2024
Zhen Su Director May 29, 2024
Barry E. Greene Director May 29, 2024
Christy J. Oliger Director May 29, 2024

Recent Insider Transactions by Companies or Individuals for Karyopharm Therapeutics Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.